Literature DB >> 21347788

Glucose-regulated protein 78 (GRP78) mediated the efficacy to curcumin treatment on hepatocellular carcinoma.

Yu-Jia Chang1, Cheng-Jeng Tai, Li-Jen Kuo, Po-Li Wei, Hung-Hua Liang, Tsan-Zon Liu, Weu Wang, Chen-Jei Tai, Yuan-Soon Ho, Chih-Hsiung Wu, Ming-Te Huang.   

Abstract

BACKGROUND: Glucose-regulated protein 78 (GRP78) plays an important role in the therapeutic treatment and progression of cancer. However, little is known about the effect of GRP78 expression to curcumin in hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: In this study, we generated GRP78 knockdown cells (GRP78KD) by a short interfering RNA (siRNA) technique. The antiproliferation effects of curcumin were determined by MTT assay, TUNEL assay, and cell cycle determination.
RESULTS: We found that GRP78KD cells were more resistant to curcumin treatment compared with the parental cells in MTT assay. The apoptosis cell population was increased in scrambled-siRNA cells treated with curcumin compared with GRP78KD cells in cell cycle distribution and TUNEL assays. Finally, we found that knocking down GRP78 causes resistance to curcumin treatment through the suppression of caspase-3 and caspase-8 expression levels.
CONCLUSIONS: We conclude that the expression level of GRP78 may contribute to the therapeutic effect of curcumin on HCC cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21347788     DOI: 10.1245/s10434-011-1597-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  14 in total

1.  MicroRNA-200a/b influenced the therapeutic effects of curcumin in hepatocellular carcinoma (HCC) cells.

Authors:  Hung-Hua Liang; Po-Li Wei; Chin-Sheng Hung; Chun-Te Wu; Weu Wang; Ming-Te Huang; Yu-Jia Chang
Journal:  Tumour Biol       Date:  2013-06-13

2.  Effect of glucose-regulated protein 94 and endoplasmic reticulum modulator caspase-12 in medial prefrontal cortex in a rat model of posttraumatic stress disorder.

Authors:  Dongmei Zhao; Fang Han; Yuxiu Shi
Journal:  J Mol Neurosci       Date:  2014-03-09       Impact factor: 3.444

3.  GRP78 mediates the therapeutic efficacy of curcumin on colon cancer.

Authors:  Yu-Jia Chang; Chien-Yu Huang; Chin-Sheng Hung; Wei-Yu Chen; Po-Li Wei
Journal:  Tumour Biol       Date:  2014-10-04

4.  Impact of Nano Preparation of Phytoconstituents in Medulloblastoma.

Authors:  Priyanka Mishra; Y B Tripathi
Journal:  Methods Mol Biol       Date:  2022

Review 5.  The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases.

Authors:  S Park; K W Mathis; I K Lee
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

6.  Synergistic effect of fenretinide and curcumin for treatment of non-small cell lung cancer.

Authors:  Huanxian Chen; Linmin Chen; Liang Wang; Xinhua Zhou; Judy Yuet-Wa Chan; Jingjing Li; Guozhen Cui; Simon Ming-Yuen Lee
Journal:  Cancer Biol Ther       Date:  2016-09-15       Impact factor: 4.742

7.  Silencing A7-nAChR levels increases the sensitivity of gastric cancer cells to ixabepilone treatment.

Authors:  Chao-Chiang Tu; Chien-Yu Huang; Wan-Li Cheng; Chin-Sheng Hung; Yu-Jia Chang; Po-Li Wei
Journal:  Tumour Biol       Date:  2016-01-20

8.  Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.

Authors:  Ran Tao; Chengzhang Wang; Yin Lu; Changwei Zhang; Hao Zhou; Hongxia Chen; WenJun Li
Journal:  Int J Nanomedicine       Date:  2020-04-22

9.  A Catalog of Proteins Expressed in the AG Secreted Fluid during the Mature Phase of the Chinese Mitten Crabs (Eriocheir sinensis).

Authors:  Lin He; Qing Li; Lihua Liu; Yuanli Wang; Jing Xie; Hongdan Yang; Qun Wang
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

10.  Clusterin protects hepatocellular carcinoma cells from endoplasmic reticulum stress induced apoptosis through GRP78.

Authors:  Cun Wang; Kai Jiang; Dongmei Gao; Xiaonan Kang; Chun Sun; Qinle Zhang; Yan Li; Lu Sun; Shu Zhang; Kun Guo; Yinkun Liu
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.